News

Immuno-Oncology Sector Deals Dominate 2017 Life Sciences Deal of the Year Awards

Bristol-Myers Squibb acquisition of IFM Therapeutics, and Amgen-CytomX licensing deal recognized among more than 4,000 transactions in annual Cortellis Deal of the Year Awards from Clarivate Analytics  Philadelphia, USA. March 7th 2018: The rapidly innovating immuno-oncology sector is transforming the cancer treatment landscape, and the results of the Clarivate Cortellis 2017 “Deal of the Year” […]

Clarivate Analytics Completes Executive Leadership Team with Appointment of New President for Life Sciences Division

Mukhtar Ahmed brings 25+ years’ experience in pharmaceutical, technology and life sciences industries Philadelphia, USA:  January 9th, 2018 – Clarivate Analytics, the global leader in providing trusted insights and analytics to accelerate the pace of innovation and commercialize ideas, has announced the appointment of Mukhtar Ahmed to the position of President – Life Sciences. His […]

Clarivate Analytics collaborates with the University of Melbourne

Clarivate Analytics collaborates with the University of Melbourne to support the ARC Training Centre for Personalized Therapeutics Technologies in advancing Australian biomedical research   MELBOURNE, June  16, 2017 – Clarivate Analytics announced its collaboration with the University of Melbourne, which is leading the ARC Training Centre for Personalized Therapeutics Technologies, a collaboration between University of Melbourne, Monash […]

Kate Kuhrt appointed to CPhI Advisory Board

PHILADELPHIA, May 9, 2017 – CPhI Worldwide, organized by UBM EMEA, and recognized as the world’s largest pharmaceutical trade show, has appointed Kate Kuhrt, Head of Go To Market for Life Sciences at Clarivate Analytics, to its Advisory Board. Kuhrt is a prominent industry analyst and leading authority on the global active pharmaceutical ingredient (API) and […]

Target Druggability from Clarivate Analytics a Bio-IT World Best Practices finalist

PHILADELPHIA, April 24, 2017 – Target Druggability, the latest application from the Clarivate Analytics Drug Research Advisor suite of tools, was selected as a finalists in Bio-IT World’s 2017 Best Practices Awards. The Bio-IT World Best Practices Awards highlight outstanding innovations and developments in the world of life sciences, bringing together a unique group of […]

Clarivate Analytics launches new product suite, reducing risk and saving time for researchers selecting next drug target

Drug Research Advisor enables faster access and more informed decision-making with just one tool, using best in class visualization and analytics. PHILADELPHIA, March 15, 2017  — In the field of drug discovery, selecting a target for preclinical development is difficult, and selecting the right target is arguably the most important step in the entire drug discovery process. Taking […]

Drug Research Advisor from Clarivate Analytics a Finalist in the Fierce Innovation Awards Data Analytics/Business Intelligence Category

PHILADELPHIA, Dec. 22, 2016 — With 65% of drug development failures occurring because the wrong target was selected, researchers need intelligence to support their next choice. Providing this sophisticated business intelligence is why Drug Research Advisor – Target Druggability, a new tool from Clarivate Analytics, was selected as one of five finalists in the Fierce Innovation Awards, Life […]